Global Antibody Discovery Market
Pharmaceuticals

Antibody Discovery Market Growth Through 2030 Creates New Strategic Opportunities

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Antibody Discovery Market Forecast Highlighting Growth From $10.74 Billion To $15.79 Billion

The market for antibody discovery has experienced robust expansion in recent years, with projections showing an increase from $9.78 billion in 2025 to $10.75 billion in 2026, representing a compound annual growth rate (CAGR) of 9.8%. This historical growth can be explained by factors such as greater research and development funding dedicated to antibody discovery, a growing occurrence of both infectious and chronic illnesses, progress made through hybridoma technology, financial support from governments for biotech research, and partnerships formed between academic institutions and pharmaceutical companies.

The antibody discovery market is projected to experience considerable expansion in the upcoming years. Its value is expected to reach $15.79 billion by 2030, advancing at a compound annual growth rate (CAGR) of 10.1%. Demand for personalized medicine, the integration of artificial intelligence and machine learning into drug development, the growing biologics sector, the use of high-throughput screening systems, and an increased emphasis on immunotherapy and targeted treatments are all driving this forecast period growth. Key developments anticipated during this timeframe involve progress in high-throughput screening methods, breakthroughs in monoclonal antibodies, customized antibody-based therapies, the creation of multi-specific antibodies, and innovations in antibody engineering.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Antibody Discovery Market Development Factors: Which Trends Are Supporting Demand?

The rising demand for precision therapeutics is anticipated to fuel expansion in the antibody discovery market. Precision therapeutics, or personalized therapeutics, involves tailoring medical treatments and interventions to match each patient’s unique characteristics. In this context, antibody discovery plays a key role by facilitating the creation of targeted therapies, such as monoclonal antibodies, which are specifically engineered to interact with disease-related molecules or cells, offering more precise and customized treatment options. For example, IQVIA Holdings Inc., a US-based company specializing in advanced analytics, technology solutions, and clinical research services for life sciences and healthcare, reported in March 2024 that global expenditures on cell and gene therapies reached $5.9 billion in 2023, representing a 38% increase compared to 2022. Consequently, the increasing emphasis on precision therapeutics is set to propel growth in the antibody discovery market.

Antibody Discovery Market Segmentation Trends And Revenue Drivers

The antibody discovery market covered in this report is segmented –

1) By Methods: Phage Display, Hybridoma, Other Methods

2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody

3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

Subsegments:

1) By Phage Display: Selection And Screening Techniques, Optimization Methods

2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes

3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

Antibody Discovery Market Transformation Trends: Which Innovations Are Driving Change?

Key players in the antibody discovery market are advancing cutting-edge technologies, including AI-powered computational platforms for antibody drug discovery, to enhance both the speed and accuracy of antibody development. Such a platform leverages artificial intelligence and computational methods to accelerate the identification and refinement of therapeutic antibodies. For example, in October 2023, SwiftPharma BV, a Belgium-based firm specializing in recombinant proteins from a plant-derived system, launched an AI-driven antibody discovery platform. This innovative system integrates artificial intelligence, big data, machine learning, and phage display techniques to rapidly forecast high-specificity, high-affinity antibody-antigen interactions. Similar to natural language processing, it generates numerous antibody variants, allowing SwiftPharma to efficiently construct extensive antibody libraries. This advanced solution facilitates the swift discovery of potential antibody drugs, achieving remarkable speed.

Antibody Discovery Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the antibody discovery market are Charles River Laboratories, WuXi Biologics, Genmab A/S, Evotec, ChemPartner, Aragen Life Science Pvt. Ltd., GenScript Technology Corporation, Biocytogen, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A., Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio Technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

Access The Complete Antibody Discovery Market Report:

https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Antibody Discovery Market Largest Region By Revenue And Market Share

North America was the largest region in the antibody discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model